Medicare Enrolled

Dr. Douglas Russell, DO

Urology Physician · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3327 RESEARCH PLZ STE 403, San Antonio, TX 78235
2103376228
In practice since 2013 (12 years)
NPI: 1912343096 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Russell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Russell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Russell

Dr. Douglas Russell is an urology physician in San Antonio, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Russell performed 3,271 Medicare services across 1,948 unique beneficiaries.

Between the years covered by Open Payments, Dr. Russell received a total of $3,503 from 35 pharmaceutical and/or device companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Russell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 36% volume in TX $3,503 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,271
Medicare services
Top 36% in TX for urology physician
1,948
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~273 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infectious disease DNA/RNA test 606 $34 $78
Urinalysis with microscopic exam 576 $3 $15
Chronic care management, first 20 min/month 295 $39 $80
Blood draw (venipuncture) 293 $8 $10
Office visit, established patient (20-29 min) 285 $60 $150
Office visit, established patient (30-39 min) 275 $88 $215
PSA test (prostate cancer screening) 238 $18 $110
Bladder ultrasound after voiding 130 $7 $95
Complete ultrasound scan behind abdominal cavity 61 $74 $345
New patient office visit (45-59 min) 51 $103 $313
Testosterone (hormone) level, total 50 $25 $150
Yeast/candida DNA test 50 $34 $78
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique 49 $34 $78
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique 49 $34 $78
Diagnostic exam of bladder and urethra using an endoscope 45 $176 $490
Basic metabolic blood panel 34 $8 $45
Initial hospital admission, moderate complexity 24 $100 $275
Ultrasound scan of pelvic region through rectum 23 $101 $285
Imaging of urinary tract following injection of a contrast agent 20 $18 $360
New patient office visit (30-44 min) 18 $76 $210
Complete blood count (CBC) with differential 16 $8 $25
Simple insertion of temporary bladder tube 15 $41 $180
Insertion of stent in ureter using an endoscope 15 $95 $1,200
Hospital follow-up visit, low complexity 15 $38 $90
Psa (prostate specific antigen) measurement, free 13 $18 $150
Analysis for detection of tumor marker 13 $20 $115
Simple bladder irrigation and/or instillation 12 $58 $215
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
7.2% medium
92.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,503
Total received (2018-2024)
Avg $500/year across 7 years
Top 47% in TX for urology physician
35
Companies
116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,418 (69.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$952 (27.2%)
Scientific / Research
Research funding and grants
$133 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$416
2023
$332
2022
$691
2021
$339
2020
$372
2019
$875
2018
$477

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$795
NeoTract Inc.
$305
Janssen Biotech, Inc.
$282
PFIZER INC.
$226
Boston Scientific Corporation
$222
PROCEPT BioRobotics Corporation
$187
Teleflex LLC
$160
BOSTON SCIENTIFIC CORPORATION
$133
Axonics, Inc.
$132
Dendreon Pharmaceuticals LLC
$105
Novartis Pharmaceuticals Corporation
$84
Allergan Inc.
$72
Ferring Pharmaceuticals Inc.
$66
Endo Pharmaceuticals Inc.
$64
Bayer HealthCare Pharmaceuticals Inc.
$64
Blue Earth Diagnostics Limited
$55
TOLMAR Pharmaceuticals, Inc.
$51
Sun Pharmaceutical Industries Inc.
$51
Merck Sharp & Dohme LLC
$49
Sumitomo Pharma America, Inc.
$41
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
AstraZeneca Pharmaceuticals LP
$37
ABBVIE INC.
$31
UROVANT SCIENCES INC
$29
Clarus Therapeutics Inc.
$27
Myriad Genetic Laboratories, Inc.
$27
Melinta Therapeutics, Inc.
$26
Amgen Inc.
$24
Merck Sharp & Dohme Corporation
$20
CONMED Corporation
$19
Antares Pharma, Inc.
$19
UROGEN PHARMA, INC.
$19
Avadel Specialty Pharmaceuticals, LLC
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
AbbVie Inc.
$14
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axumin · BALVERSA · BOTOX · BOTOX THERAPEUTIC · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · JATENZO · JELMYTO · KEYTRUDA · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · Orbactiv · PLUVICTO · PROLARIS · PROVENGE · TAGRISSO · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · Vabomere · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $107 per 100 Medicare services performed
Looking for an urology physician in San Antonio?
Compare urology physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
99
Per 100K population
4.9
County median income
$70,571
Nearest hospital
SAN ANTONIO STATE HOSP STATE SCHOOL
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Russell is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Russell experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Russell performed 606 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Russell receive payments from pharmaceutical companies?
Yes. Dr. Russell received a total of $3,503 from 35 companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Russell's costs compare to other urology physicians in San Antonio?
Dr. Russell's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Russell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →